Monday, August 20, 2018

Pascal Apostolides

General Manager, AbbVie Pharmaceuticals SA
President, SFEE

Pascal Apostolides
Pascal Apostolides

Holder of a BSc degree in Chemistry, a BA in Economic Geography and a post graduate degree in Pharmaceutical Chemistry from the University of Manitoba, Winnipeg, Canada. He also received a MSc in Environmental Chemistry from the University of Stratchclyde, Glasgow, Scotland.

He worked for 7 years in the German affiliate and 4 years at Abbott Park Chicago. In 2001 he returned to Greece as Managing Director of Abbott Laboratories Hellas.

Since January 2013, Pascal Apostolides holds the position of the Managing Director of AbbVie, a new, independent, global biopharmaceutical which retains in its portfolio innovative medicines for serious and chronic diseases, following Abbott’s separation in two individual companies.

He is President of the Hellenic Association of Pharmaceutical Companies (SFEE). Member of the Executive Committee of the Pharma Innovation Forum (PIF) as well as Member of the Pharma Committee of the Hellenic-American Chamber of Commerce (AmCham) and member of the BoD. Furthermore, he is a member of the Executive Board of Trustees/Treasurer of the American Community Schools of Athens (ACS).

Keynote Speaker

Stephen Palmer Stephen Palmer is a Professor and Deputy Director of TEEHTA. He has worked in economic evaluation for over 15 years in areas including pharmaceuticals, cardiology, cancer, mental health, diagnostic and screening programmes and policy. He has extensive experience of health economic evaluation, regulatory and reimbursement processes.

© 2018 Boussias Communications, all rights reserved., T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team